Dr. John Cush RheumNow
6 years 6 months ago
FDA fact sheet for patients and parent/caregivers regarding the emergency use autorization (EUA) of hydroxychloroquine sulfate for the treatment of COVID-19 in certain hospitalized patients https://t.co/6RPQQpGW6X
Dr. John Cush RheumNow
6 years 6 months ago
On 3/31/20 the FDA granted "emergency use authorization" for the use of chloroquine and hydroxychloroquine in the treatment of COVID-19, noting circumstances exist justifying the authorization of emergency use of these agents https://t.co/3h99aZmMCn
Dr. Jack Cush reviews the news on COVID-19 and FDA actions this past week. Be sure to check out:
COVID Town Hall Meeting for Rheumatology
COVID Q&A with the Experts: Drs. Cassie Calabrese, Jack Cush, Artie Kavanaugh, Alan Matsumoto, Alvin Wells & Kevin Winthrop
Dr. John Cush RheumNow
6 years 6 months ago
ACR advice for Talking to Patients About Shortages of Hydroxychloroquine During the COVID-19 Pandemic https://t.co/ja7NHyDcKm
Dr. John Cush RheumNow
6 years 6 months ago
The BMJ ha published a rheumatoid arthritis patient perspective on the challenges of the COVID-19 pandemic https://t.co/HayLWB40Mw
Dr. John Cush RheumNow
6 years 6 months ago
Testing Individuals for Coronavirus Disease 2019 (COVID-19) - overview and infographic from JAMA https://t.co/kYKhfzjbhp
In early March 2020, there were widespread recommendations that wearing routine "surgical masks" by the public sector was not likely to be helpful or advisable. Now we are hearing of a 180 degree shift in thinking with the CDC, leading health officials and the current NEJM Perspective pointing to more widespread use of masks by healthcare workers and even by individuals in the public sector.
Dr. John Cush RheumNow
6 years 6 months ago
Weekly RheumNow Podcast is up! NEW WORLD ORDER; watch it here>> https://t.co/2VDHWoFq28 or listen to the podcast on iTunes or SoundCloud >> https://t.co/ElB9S9nlzY
Dr. John Cush RheumNow
6 years 6 months ago
ID Specialist Dr. Jade Le answers questions about COVID - PPE, Masks, Package deliveries, Managing rheum Pts w/ suspicious Sxs, Testing and consulting ID. Watch here>>https://t.co/o79FJ8QhDY or listen on iTunes or here>> https://t.co/7kwcnAmqaA
Q & A with ID: Dr. Jade Le
Dr. Jade Le is an infectious disease specialist in Dallas, TX
Dr. John Cush RheumNow
6 years 6 months ago
FDA Requests Removal of All Ranitidine (Zantac) from the Market - based on its investigation of the contaminant N-Nitrosodimethylamine (NDMA) in ranitidine; the impurity in ranitidine products increases over time, esp at higher temps https://t.co/BJxLDfpbtS
Dr. John Cush RheumNow
6 years 6 months ago
Michelle Petri, MD, MPH - Managing Hydroxychloroquine | RheumNow - Rheumatology News & Information https://t.co/eLUR3N3L9m
Dr. John Cush RheumNow
6 years 6 months ago
RA-BioDAM study from 10 countries and 4356 visits, 571 patients finds T2T practiced in 59% of pts. The benefits of T2T were seen after 3 mos with significantly more remissions at 2 years. https://t.co/Gqrl0ARyzp
